Using corneal cross-linking (CXL), progressive keratoconus and other corneal ectatic diseases can be treated with minimal invasiveness. To strengthen the cornea and stop the progression of the condition, riboflavin (vitamin B2) eye drops are applied followed by exposure to ultraviolet (UV) light.
The following should be done before corneal cross-linking:
To determine the severity and progression of corneal disease, patients undergo a comprehensive eye examination.
Patients should discuss the procedure with their eye care provider and address any concerns.
Following are the steps involved in corneal cross-linking:
To ensure the patient's comfort during the procedure, anesthesia eye drops are administered.
A riboflavin eye drop is applied to the cornea, allowing it to penetrate and saturate the corneal tissue.
A chemical reaction occurs when the cornea is exposed to ultraviolet light, which activates the riboflavin and strengthens the collagen fibers.
In order to ensure proper absorption of riboflavin and exposure to UV light, the eye care provider monitors the procedure.
After corneal cross-linking:
Following the procedure, patients may experience mild discomfort, sensitivity to light, and blurred vision for a short period of time.
During recovery, eye drops may be prescribed to reduce inflammation and prevent infection.
In order to monitor the healing process and assess the effectiveness of the treatment, follow-up visits are typically scheduled.
Even though corneal cross-linking is considered safe and effective, there are some potential risks and complications, including:
Haze on the cornea: Some patients experience corneal haze for a short period of time, which usually resolves on its own.
The procedure can result in corneal infection in rare cases.
In some cases, corneal cross-linking may not halt the progression of the corneal condition completely, requiring additional treatment.
After corneal cross-linking, the following steps should be taken to promote optimal healing and outcomes:
To prevent irritation or infection, patients should avoid rubbing or touching their eyes during the recovery period.
It is essential to follow the prescribed medication regimen and use eye drops according to the eye care provider's instructions.
To protect their eyes from excessive sunlight exposure during the healing process, patients should wear sunglasses with UV protection.
The use of corneal cross-linking can help stabilize and strengthen the cornea in patients with progressive keratoconus and other corneal ectatic disorders, preventing the need for more invasive interventions such as corneal transplants.
